Danimer Scientific, Inc. announced that Stephen E. Croskrey has resigned from his position as Chairman of the Board, effective May 20, 2024, though he will continue to serve on the Board through his current term and will be a nominee for reelection at this year?s annual meeting of stockholders. The Board has appointed Richard J. Hendrix as Chairman, serving in that role upon Mr. Croskrey?s resignation as Chairman. Mr. Hendrix also will serve as Interim Executive Chairman during the period of transition to identify a CEO to succeed Mr. Croskrey.

Additionally, the Board has formed an Executive Committee comprised of Mr. Hendrix, John Amboian, David Moody, and Mr. Croskrey. The Executive Committee will be charged with leading the search process for a new CEO, along with oversight of strategy and shareholder engagement during the transition period.